280 filings
Page 11 of 14
UPLOAD
wmzzxhetkwq
4 May 20
Letter from SEC
12:00am
DRS
6w1qcnztt20nom0
27 Apr 20
Draft registration statement
12:00am
DEF 14A
ohny1wu
22 Apr 20
Definitive proxy
4:45pm
8-K
ayzlif bh8xpd07ixgf
30 Mar 20
ONSET-2 Phase 3 Top-Line Data Expected by End of Q2 2020
7:33am
8-K
d9nwp
27 Feb 20
Oyster Point Pharma Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights
4:09pm
10-K
8mi8yeapv17ze8 io
27 Feb 20
Annual report
12:00am
4
n9de8zp
5 Feb 20
Oyster Point Pharma / Jeffrey Nau ownership change
4:11pm
4
zkdciw2l5nwgqh3jl
5 Feb 20
Oyster Point Pharma / John Snisarenko ownership change
4:11pm
4
z9hov0
5 Feb 20
Oyster Point Pharma / Daniel Lochner ownership change
4:10pm
8-K
bmwyoikc
14 Jan 20
Regulation FD Disclosure
8:01am
8-K
tq6g 0i9d8gdrqq8
13 Jan 20
Regulation FD Disclosure
8:00am
10-Q
sabeldtty3a gy90m3
3 Dec 19
Quarterly report
7:24am
8-K
bikaiunnar4v0rdu
3 Dec 19
Results of Operations and Financial Condition
7:17am
SC 13D
3i2re091w1u
14 Nov 19
Oyster Point Pharma, Inc.
5:34pm
SC 13D
ayu6 o4vkg5
14 Nov 19
Oyster Point Pharma, Inc.
2:45pm
SC 13D
6tm gvkzul
7 Nov 19
Oyster Point Pharma, Inc.
9:47pm
4
gvts5rp
6 Nov 19
Oyster Point Pharma / GP IV, L.L.C. InvOpps ownership change
4:30pm
8-K
o7wphi3r2r
5 Nov 19
Oyster Point Pharma Announces Pricing of Initial Public Offering
5:15pm
4
fhbf1mlp
5 Nov 19
Oyster Point Pharma / John Snisarenko ownership change
6:08am